Sex-specific associations between thyrotropin and serum lipid profiles

Thyroid

Volumn 24, Issue 3, 2014, Pages 424-432

  Meisinger, Christa ^a,b   Ittermann, Till ^c   Tiller, Daniel ^d   Agger, Carsten ^e   Nauck, Matthias ^c   Schipf, Sabine ^c   Wallaschofski, Henri ^c   Jørgensen, Torben ^e,f   Linneberg, Allan ^e   Thiery, Joachim ^g   Kluttig, Alexander ^d   Greiser, Karin H ^d,h   Werdan, Karl ^d   Burkhardt, Katrin ^a,b   Völzke, Henry ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b KLINIKUM AUGSBURG   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF LEIPZIG   (Germany)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY ANALYSIS; SEX DIFFERENCE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN EUROPE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; REFERENCE VALUES; THYROTROPIN; YOUNG ADULT;

EID: 84896757461     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0259     Document Type: Article

References (52)

1. Dimitriadis GD, Raptis SA 2001 Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 109:S225-S239.
2. Duntas LH, Brenta G 2012 The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am 96:269-281.
3. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N; Thyroid Studies Collaboration 2012 Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 172:799-809.
4. Iglesias P, Diez JJ 2007 Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 40:61-70.
5. Hsieh CJ, Wang PW 2008 Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function. Endocr J 55:489-494.
6. Crunkhorn S, Patti ME 2008 Links between thyroid hormone action, oxidative metabolism, and diabetes risk? Thyroid 18:227-237.
7. Fernandez-Real JM, Lopez-Bermejo A, Castro A, Casamitjana R, Ricart W 2006 Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 91:3337-3343.
8. Völzke H, Robinson DM, Spielhagen T, Nauck M, Obst A, Ewert R,Wolff B, Wallaschofski H, Felix SB, Dörr M 2009 Are serum thyrotropin levels within the reference range associated with endothelial function? Eur Heart J 30:217-224.
9. Auer J, Berent R, Weber T, Lassnig E, Eber B 2003 Thyroid function is associated with presence and severity of coronary atherosclerosis. Clin Cardiol 26:569-573.
10. Völzke H, Robinson DM, Schminke U, Lüdemann J, Rettig R, Felix SB, Kessler C, John U, Meng W 2004 Thyroid function and carotid wall thickness. J Clin Endocrinol Metab 89:2145-2149.
11. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R 2007 Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) 67:265-269.
12. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L, Jørgensen T 2005 Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90:4019-4024.
13. Pearce EN 2012 Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 97:326-333.
14. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P 1985 The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 145:1386-1388.
15. Flynn RW, MacDonald TM, Morris AD, Jung RT, Leese GP 2004 The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population. J Clin Endocrinol Metab 89:3879-3884.
16. Tognini S, Polini A, Pasqualetti G, Ursino S, Caraccio N, Ferdeghini M, Monzani F 2012 Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: Results from a large cross-sectional study. Thyroid 22:1096-1103.
17. Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DCG, Luben R, Wareham NJ, Khaw KT 2010 Initial thyroid status and cardiovascular risk factors: the EPICNorfolk prospective population study. Clin Endocrinol (Oxf) 72:404-410.
18. Asvold BO, Vatten LJ, Nilsen TIL, Bjoro T 2007 The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 156:181-186.
19. Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, Havemann C, Ittermann T, Schipf S, Haring R, Baumeister SE, Wallaschofski H, Nauck M, Frick S, Arnold A, Jünger M, Mayerle J, Kraft M, Lerch MM, Dörr M, Reffelmann T, Empen K, Felix SB, Obst A, Koch B, Gläser S, Ewert R, Fietze I, Penzel T, Dören M, Rathmann W, Haerting J, Hannemann M, Röpcke J, Schminke U, Jürgens C, Tost F, Rettig R, Kors JA, Ungerer S, Hegenscheid K, Kühn JP, Kühn J, Hosten N, Puls R, Henke J, Gloger O, Teumer A, Homuth G, Völker U, Schwahn C, Holtfreter B, Polzer I, Kohlmann T, Grabe HJ, Rosskopf D, Kroemer HK, Kocher T, Biffar R, John U, Hoffmann W 2011 Cohort profile: the study of health in Pomerania. Int J Epidemiol 40:294-307.
20. Meisinger C, Rückert IM, Rathmann W, Döring A, Thorand B, Huth C, Kowall B, Koenig W 2011 Retinol-binding protein 4 is associated with prediabetes in adults from the general population: the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study. Diabetes Care 34:1648-1650.
21. Greiser KH, Kluttig A, Schumann B, Kors JA, Swenne CA, Kuss O, Werdan K, Haerting J 2005 Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the CARdiovascular disease, Living and Ageing in Halle (CARLA) Study. BMC Cardiovasc Disord 5:33.
22. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C 2003A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results INTER99. Eur J Cardiovasc Prev Rehabil 10:377-386.
23. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL; American Association of Clinical Endocrinologists 2002 American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8:457-469.
24. Royston P, Sauerbrei W 2008 Multivariable Model-building: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables. John Wiley, Chichester, United Kingdom.
25. Iqbal A, Jorde R, Figenschau Y 2006 Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med 260:53-61.
26. Santos-Palacios S, Brugos-Larumbe A, Guillen-Grima F, Galofre JC 2013 A cross-sectional study of the association between circulating TSH level and lipid profile in a large Spanish population. Clin Endocrinol (Oxf) 79:874-881.
27. Garduno-Garcia Jde, Alvirde-Garcia U, Lopez-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Aguilar-Salinas CA 2010 TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol 163:273-278.
28. Wang F, Tan Y, Wang C, Zhang X, Zhao Y, Song X, Zhang B, Guan Q, Xu J, Zhang J, Zhang D, Lin H, Yu C, Zhao J 2012 Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones. Endocrinol Metab 97:2724-2731.
29. Lee YK, Kim JE, Oh HJ, Park KS, Kim SK, Park SW, Kim MJ, Cho YW 2011 Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean J Intern Med 26:432-439.
30. Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR 2007 Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf) 66:548-556.
31. Kung AW, Pang RW, Lauder I, Lam KS, Janus ED 1995 Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism. Clin Chem 41:226-231.
32. Aviram M, Luboshitzky R, Brook JG 1982 Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem 15:62-66.
33. Pearce EN, Wilson PW, Yang Q, Vasan RS, Braverman LE 2008 Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort. J Clin Endocrinol Metab 93:888-894.
34. Al-Tonsi AA, Abdel-Gayoum AA, Saad M 2004 The secondary dyslipidemia and deranged serum phosphate concentration in thyroid disorders. Exp Mol Pathol 76:182-187.
35. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 Lipid profiles and cardiovascular disease in the Wickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 7:495-508.
36. Pucci E, Chiovato L, Pinchera A 2000 Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 24:S109-112.
37. Constantini F, Pierdomenico SD, De Cesare D, De Remigis P, Bucciarelli T, Bittolo-Bon G, Cazzolato G, Nubile G, Guagnano MT, Sensi S, Cuccurullo F, Mezzetti A 1998 Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 18:732-737.
38. Gjedde S, Gormsen LC, Rungby J, Nielsen S, Jørgensen JO, Pedersen SB, Riis AL, Weeke J, Møller N 2010 Decreased lipid intermediate levels and lipid oxidation rates despite normal lipolysis in patients with hypothyroidism. Thyroid 20:843-849.
39. Duntas LH, Biondi B 2011 New insights into subclinical hypothyroidism and cardiovascular risk. Semin Thromb Hemost 37:27-34.
40. Mariotti S, Cambuli VM 2007 Cardiovascular risk in elderly hypothyroid patients. Thyroid 17:1067-1073.
41. Galofre JC, Frühbeck G, Salvador J 2010 Obesity and thyroid function: pathophysiological and therapeutic implications. Hot Thyroidology 6:1-22. Available at: www .hotthyroidology.com/editorial-214.html (accessed June 7, 2013).
42. Chubb SA, Davis WA, Davis TM 2005 Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle Diabetes Study. J Clin Endocrinol Metab 90:5317-5320.
43. Rawal R, Teumer A, Völzke H, Wallaschofski H, Ittermann T, Asvold BO, Bjøro T, Greiser KH, Tiller D, Werdan K, Schwabedissen HE, Doering A, Illig T, Gieger C, Meisinger C, Homuth G 2012 Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function. Hum Mol Genet 21:3275-3282.
44. Carr MC, Hokanson JE, Zambon A, Deeb SS, Barrett PHR, Purnell JQ, Brunzell JD 2001 The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J Clin Endocrinol Metab 86:2831-2837.
45. Koutsari C, Basu R, Rizza RA, Nair KS, Khosla S, Jensen MD 2011 Nonoxidative free fatty acid disposal is greater in young women than men. J Clin Endocrinol Metab 96:541-547.
46. Schindler AE 2003 Thyroid function and postmenopause. Gynecol Endocrinol 17:79-85.
47. Zuckerman SH, Evans GF, Schelm JA, Eacho PI, Sandusky G 1999 Estrogen-mediated increases in LDL cholesterol and foam cell-containing lesions in human ApoB100xCETP transgenic mice. Arterioscler Thromb Vasc Biol 19:1476-1483.
48. Badeau RM, Metso J, Kovanen PT, Lee-Rueckert M, Tikkanen MJ, Jauhiainen M 2013 The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport. Eur J Clin Invest 43:317-323.
49. Ozbey N, Sencer E, Molvalilar S, Orhan Y 2002 Body fat distribution and cardiovascular disease risk factors in preand potstmenopausal obese women with similar BMI. Endocr J 49:503-509.
50. Scobbo RR, VonDohlen TW, Hassan M, Islam S 2004 Serum TSH variability in normal individuals: the influence of time of sample collection. W V Med J 100:138-142.
51. Craig SR, Amin RV, Russell DW, Paradise NF 2000 Blood cholesterol screening influence of fasting state on cholesterol results and management decisions. J Gen Intern Med 15:395-399.
52. Surks MI, Goswami G, Daniels GH 2005 The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 90:5489-5496.